Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs

Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs Publisher

Sharifi A^{1, 2} ; Mahdieh N^{1, 3}

Show Affiliations

1. Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran
2. Premarital Counseling Center of Ilam University of Medical Sciences, Ilam, Iran
3. Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Clinical Case Reports Published:2021

Abstract

HbA2 level alone for beta thalassemia trait may not be accurate and reliable even without iron deficiency so molecular genetic testing is important and should be considered for some individuals. © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

2. Gfap Variants Leading to Infantile Alexander Disease: Phenotype and Genotype Analysis of 135 Cases and Report of a De Novo Variant, Clinical Neurology and Neurosurgery (2021)

3. A Novel Pathogenic Variant of Srd5a2 in an Iranian Psuedohermaphrodite Male, Clinical Case Reports (2020)

Experts (# of related papers)

Mahmoudreza Ashrafi (1)

Ali Reza Tavasoli (1)

Style	Citing Format
MLA	Sharifi A, Mahdieh N. "Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs." Clinical Case Reports, vol. 9, no. 2, 2021, pp. 973-977.
APA	Sharifi A, Mahdieh N (2021). Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs. Clinical Case Reports, 9(2), 973-977.
Chicago	Sharifi A, Mahdieh N. "Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs." Clinical Case Reports 9, no. 2 (2021): 973-977.
Harvard	Sharifi A, Mahdieh N (2021) 'Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs', Clinical Case Reports, 9(2), pp. 973-977.
Vancouver	Sharifi A, Mahdieh N. Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs. Clinical Case Reports. 2021;9(2):973-977.
BibTex	@article{ author = {Sharifi A and Mahdieh N}, title = {Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs}, journal = {Clinical Case Reports}, volume = {9}, number = {2}, pages = {973-977}, year = {2021} }
RIS	TY - JOUR AU - Sharifi A AU - Mahdieh N TI - Hbb Mutations and Hba2 Level: Escaping the Carrier Screening Programs JO - Clinical Case Reports VL - 9 IS - 2 SP - 973 EP - 977 PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract